Table 1 Distribution of HER2 amplification results in ovarian tumours from BRCA1 and BRCA2 carriers and non-carriers
From: HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours
HER2 amplification status | BRCA1 | BRCA2 | Non-carriers |
|---|---|---|---|
n (%) | n (%) | n (%) | |
high amplification | 2 (11) | 2 (100) | 2 (6) |
low and moderate amplification | 2 (11) | 0 | 2 (6) |
total amplified | 4 (22) | 2 (100) | 4 (12) |
no amplification | 14 (78) | 0 | 29 (88) |
total | 18 | 2 | 33 |